InvestorsHub Logo
Followers 3
Posts 70
Boards Moderated 0
Alias Born 02/06/2016

Re: None

Tuesday, 02/23/2016 10:14:20 PM

Tuesday, February 23, 2016 10:14:20 PM

Post# of 3683
north40000 re1570,1569.
Thanks for the Wechsler slides (excellent review of this RDB trial to date) and its promising cost efficacy implications.
Also for your speculations on the buy/merger with Healios.
The clinical efficacy of the active ingredient was NOT zero, it;s efficacy was clinically substantial at 90 days,but it was NOT STAT. significantly superior to the the placebo group at 90 days.
A DELAYED biological mechanism of clinical efficacy onset(Yamanaka 2012) may be implicated in the paradoxical stat.sig increased efficacy(p=0.01) at 365 days, on several measures of theoretical and clinically significant outcome.
This DELAYED onset mechanism requires replication,but is not inconsistent with biological theory.